Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen P Hunger

Showing results (151-160 of 346) with videos related to

Pageof 35
Sort By:
Leukemia|April 12, 2022
JAK3 mutations and mitochondrial apoptosis resistance in T-cell acute lymphoblastic leukemiaKimberly Bodaar, Natsuko Yamagata, Anais Barthe, et al.
Blood Advances|June 5, 2019
Excellent long-term survival of children with Down syndrome and standard-risk ALL: a report from the Children's Oncology GroupYousif Matloub, Karen R Rabin, Lingyun Ji, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2009
Phase I and pharmacokinetic study of cetuximab and irinotecan in children with refractory solid tumors: a study of the pediatric oncology experimental therapeutic investigators' consortiumTanya M Trippett, Cynthia Herzog, James A Whitlock, et al.
JNCI Cancer Spectrum|July 31, 2019
Validation of Minimal Residual Disease as Surrogate Endpoint for Event-Free Survival in Childhood Acute Lymphoblastic LeukemiaStefania Galimberti, Meenakshi Devidas, Ausiliatrice Lucenti, et al.
Haematologica|May 19, 2018
Clinical efficacy of ruxolitinib and chemotherapy in a child with Philadelphia chromosome-like acute lymphoblastic leukemia with <i>GOLGA5-JAK2</i> fusion and induction failureYang Y Ding, Julie W Stern, Tracey F Jubelirer, et al.
JAMA Network Open|December 29, 2022
Association of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic LeukemiaWenjian Yang, Seth E Karol, Keito Hoshitsuki, et al.
Journal of the National Cancer Institute|May 16, 2022
Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic LeukemiaXujie Zhao, Maoxiang Qian, Charnise Goodings, et al.
Blood Advances|July 23, 2021
Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphomaXinjie Xu, Christian N Paxton, Robert J Hayashi, et al.
Blood|September 5, 2008
Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemiaJun J Yang, Deepa Bhojwani, Wenjian Yang, et al.
Blood|February 4, 2010
Inactivation of LEF1 in T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Takaomi Sanda, Wenxue Ma, et al.
Pageof 35

Showing results (151-160 of 346) with videos related to

Sort By:
Pageof 35
Leukemia|April 12, 2022
JAK3 mutations and mitochondrial apoptosis resistance in T-cell acute lymphoblastic leukemiaKimberly Bodaar, Natsuko Yamagata, Anais Barthe, et al.
Blood Advances|June 5, 2019
Excellent long-term survival of children with Down syndrome and standard-risk ALL: a report from the Children's Oncology GroupYousif Matloub, Karen R Rabin, Lingyun Ji, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2009
Phase I and pharmacokinetic study of cetuximab and irinotecan in children with refractory solid tumors: a study of the pediatric oncology experimental therapeutic investigators' consortiumTanya M Trippett, Cynthia Herzog, James A Whitlock, et al.
JNCI Cancer Spectrum|July 31, 2019
Validation of Minimal Residual Disease as Surrogate Endpoint for Event-Free Survival in Childhood Acute Lymphoblastic LeukemiaStefania Galimberti, Meenakshi Devidas, Ausiliatrice Lucenti, et al.
Haematologica|May 19, 2018
Clinical efficacy of ruxolitinib and chemotherapy in a child with Philadelphia chromosome-like acute lymphoblastic leukemia with <i>GOLGA5-JAK2</i> fusion and induction failureYang Y Ding, Julie W Stern, Tracey F Jubelirer, et al.
JAMA Network Open|December 29, 2022
Association of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic LeukemiaWenjian Yang, Seth E Karol, Keito Hoshitsuki, et al.
Journal of the National Cancer Institute|May 16, 2022
Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic LeukemiaXujie Zhao, Maoxiang Qian, Charnise Goodings, et al.
Blood Advances|July 23, 2021
Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphomaXinjie Xu, Christian N Paxton, Robert J Hayashi, et al.
Blood|September 5, 2008
Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemiaJun J Yang, Deepa Bhojwani, Wenjian Yang, et al.
Blood|February 4, 2010
Inactivation of LEF1 in T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Takaomi Sanda, Wenxue Ma, et al.
Pageof 35